1. Domes T, De Young L, O'Gorman DB, Gan BS, Bella AJ, Brock G. Is there a role for proteomics in Peyronie's disease? J Sex Med. 2007. 4:867–877.
2. Burnett AL. Pathophysiology of priapism: dysregulatory erection physiology thesis. J Urol. 2003. 170:26–34.
3. Liu X, Gao X, Pang J, Zhang Y, Wang K, Fang Y, et al. Proteomic analysis of rat penile tissue in a model of erectile dysfunction after radical prostatectomy. BJU Int. 2007. 99:1500–1505.
4. Suter B, Kittanakom S, Stagljar I. Interactive proteomics: what lies ahead? Biotechniques. 2008. 44:681–691.
5. Kim HJ, Youn WY, Myong NH, Hwang CH, Ryu JW, Lee YS. Proteomic approach for identifying marker proteins in the urinary bladder precancerous conditions induced by BBN (N-butyl-N-(4-hydroxybutyl) nitrosamine). Korean J Urol. 2004. 45:77–83.
6. Shim JH, Kim HJ. Investigation of oxidative stress and development of lower urinary tract symptoms in the urinary bladder following partial bladder outlet obstruction by proteomic approach. Korean J Urol. 2005. 46:1337–1343.
7. Kim HJ, Ryu YG, Hong JH, Hong JH. Proteomic analysis of the proteins that were changed by bilateral orchiectomy in the rabbit corpus cavernosum. Korean J Urol. 2008. 49:449–453.
8. Ferrini MG, Kovanecz I, Nolazco G, Rajfer J, Gonzalez-Cadavid NF. Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int. 2006. 97:625–633.
9. Nolazco G, Kovanecz I, Vernet D, Gelfand RA, Tsao J, Ferrini MG, et al. Effect of muscle-derived stem cells on the restoration of corpora cavernosa smooth muscle and erectile function in the aged rat. BJU Int. 2008. 101:1156–1164.
10. Domes T, De Young L, O'Gorman DB, Gan BS, Bella AJ, Brock G. Is there a role for proteomics in Peyronie's disease? J Sex Med. 2007. 4:867–877.
11. Bivalacqua TJ, Purohit SK, Hellstrom WJ. Peyronie's disease: advances in basic science and pathophysiology. Curr Urol Rep. 2000. 1:297–301.
12. Leungwattanakij S, Bivalacqua TJ, Usta MF, Yang DY, Hyun JS, Champion HC, et al. Cavernous neurotomy causes hypoxia and fibrosis in rat corpus cavernosum. J Androl. 2003. 24:239–245.
13. Dubbelman YD, Dohle GR, Schröder FH. Sexual function before and after radical retropubic prostatectomy: a systematic review of prognostic indicators for a successful outcome. Eur Urol. 2006. 50:711–718.
14. Lee JW, Kim CS, Ahn H. Early and late complications of radical retropubic prostatectomy. Korean J Urol. 2000. 41:1409–1414.
15. Monastyrskaya K, Tschumi F, Babiychuk EB, Stroka D, Draeger A. Annexins sense changes in intracellular pH during hypoxia. Biochem J. 2008. 409:65–75.
16. Piljic A, Schultz C. Annexin A4 self-association modulates general membrane protein mobility in living cells. Mol Biol Cell. 2006. 17:3318–3328.
17. Barwise JL, Walker JH. Annexins II, IV, V and VI relocate in response to rises in intracellular calcium in human foreskin fibroblasts. J Cell Sci. 1996. 109:247–255.
18. User HM, Hairston JH, Zelner DJ, McKenna KE, McVary KT. Penile weight and cell subtype specific changes in a post-radical prostatectomy model of erectile dysfunction. J Urol. 2003. 169:1175–1179.
19. Lysiak JJ, Yang SK, Klausner AP, Son H, Tuttle JB, Steers WD. Tadalafil increases Akt and extracellular signal-regulated kinase 1/2 activation, and prevents apoptotic cell death in the penis following denervation. J Urol. 2008. 179:779–785.
20. Ferrini MG, Kovanecz I, Sanchez S, Umeh C, Rajfer J, Gonzalez-Cadavid NF. Fibrosis and loss of smooth muscle in the corpora cavernosa precede corporal veno-occlusive dysfunction (CVOD) induced by experimental cavernosal nerve damage in the rat. J Sex Med. 2009. 6:415–428.
21. Gonzalez-Cadavid NF. Mechanisms of penile fibrosis. J Sex Med. 2009. 6:Suppl 3. 353–362.
22. Patriarca A, Eliseo T, Sinibaldi F, Piro MC, Melis R, Paci M, et al. ATP acts as a regulatory effector in modulating structural transitions of cytochrome c: implications for apoptotic activity. Biochemistry. 2009. 48:3279–3287.